跳至主要内容
临床试验/NL-OMON31950
NL-OMON31950尚未招募不适用

Effect of intrapulmonary administration of recombinant human activated protein C on local coagulation and inflammation after bronchial instillation of lipopolysaccharide in humans - Effect of intrapulmonary rhAPC on coagulation and inflammation after LPS

Academisch Medisch Centrum0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Male subjects between 18 and 35 years of age
  • No clinically significant findings during physical examination and hematological and biochemical screening
  • Normal spirometry
  • Able to communicate well with the investigator and to comply with the requirements of the study
  • No medication
  • Written informed consent

排除标准

  • Known diseases
  • A history of smoking within the last six months, or regular consumption of greater than three units of alcohol per day
  • Administration of any investigational drug within 30 days of study initiation
  • Donation of blood within 60 days, or loss of greater than 400 ml of blood within 12 weeks of study initiation
  • History of enhanced bleeding tendency
  • History of heparin-induced thrombocytopenia
  • History of serious drug-related reactions, including hypersensitivity

研究者

相似试验